| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HERON THERAPEUTICS, INC. /DE/ | Director | Common Stock | 53,960 | $70,148 | $1.30 | 30 Jan 2026 | Direct |
| HERON THERAPEUTICS, INC. /DE/ | Director | Stock Option (Right to Buy) | 35,900 | $62,107 | $1.73 | 31 Jan 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 30 Jan 2026 | 1 | $0 | 4 | Director | 03 Feb 2026, 10:00 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 31 Jan 2025 | 2 | $0 | 4/A | Director | 04 Feb 2025, 17:34 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 30 Jan 2025 | 2 | +$62,107 | 4 | Director | 03 Feb 2025, 11:48 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 19 Jan 2024 | 2 | $0 | 4 | Director | 19 Jan 2024, 21:02 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 16 Dec 2022 | 2 | $0 | 4 | Director | 20 Dec 2022, 16:20 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 22 Dec 2021 | 2 | $0 | 4 | Director | 23 Dec 2021, 17:56 |
| HRTX | HERON THERAPEUTICS, INC. /DE/ | 20 Sep 2021 | 0 | $0 | 3 | Director | 29 Sep 2021, 16:16 |